Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Chinese Hackers, Anthropic’s Claude and the First AI‑Orchestrated Cyber‑Espionage Campaign: What We Know as of November 18, 2025

Chinese Hackers, Anthropic’s Claude and the First AI‑Orchestrated Cyber‑Espionage Campaign: What We Know as of November 18, 2025

Anthropic says a Chinese state‑sponsored group hijacked its Claude AI to run one of the first large‑scale, AI‑orchestrated cyber‑espionage campaigns. Here’s a concise, up‑to‑date explainer of what happened, how the attack worked, China’s response, and what it means for security
Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Why OLMA Stock Is Exploding Today Olema Pharmaceuticals didn’t publish a press release or file anything with the SEC this morning. Yet, its stock rocketed nearly threefold in pre‑market trading on Tuesday, November 18, 2025. TipRanks The real catalyst comes
Synovus Financial (SNV) Stock: Q3 Earnings Beat, Barclays Price Target Hike and Fresh Institutional Buying – November 18, 2025

Synovus Financial (SNV) Stock: Q3 Earnings Beat, Barclays Price Target Hike and Fresh Institutional Buying – November 18, 2025

Synovus Financial Corp. (NYSE: SNV) is back in the spotlight this week as investors digest a stronger‑than‑expected third quarter, a higher price target from Barclays, and fresh 13F filings showing new institutional money flowing into the regional bank. As of
1 34 35 36 37 38 232
Go toTop